Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
FemiPro is a consumer health company focused on developing and marketing natural solutions for women's urinary and bladder health. The company's flagship product is a proprietary supplement blend designed to support the bladder microbiome and improve pelvic floor function. By utilizing a combination of botanical extracts, FemiPro aims to provide a non-pharmacological approach to managing urinary incontinence and overactive bladder symptoms. The company operates primarily in the nutraceutical space, targeting the underlying bacterial balance of the urinary tract to promote long-term wellness. FemiPro markets its products directly to consumers through digital platforms, emphasizing a holistic approach to urological health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FemiPro.